Who to call at Pfizer, and when
Fundz watches for the moments Pfizer starts buying, and tells you who to reach.
- An alert the day Pfizer raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pfizer, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pfizer. With Fundz connected, it knows.
Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug.
Contract Type
partnership
Description
Pfizer announced a partnership with Blackstone Life Sciences, securing up to $1.5 billion for the late-stage development of its GLP-1 obesity drug candidate, berobenatide. This partnership allows Pfizer to maintain operational control while providing Blackstone with milestone-based earnings tied to the program's progress.
Quick answer
Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026). Pfizer is based in New York, New York, United States.
- What agreement did Pfizer announce on November 14, 2026?
- Pfizer announced a partnership with Blackstone Life Sciences, securing up to $1.5 billion for the late-stage development of its GLP-1 obesity drug candidate, berobenatide. This partnership allows Pfizer to maintain operational control while providing Blackstone with milestone-based earnings tied to the program's progress.
- Where is Pfizer based?
- Pfizer is based in New York, New York, United States.
- Which similar companies announced agreements around the same time?
- Sino Biopharmaceutical (November 13, 2026), AbbVie Inc. (November 3, 2026), Edesa Biotech (November 9, 2026) and Teva Pharmaceutical Industries Ltd (November 3, 2026) also announced agreements within 45 days of Pfizer.
Source: Fundz verified event record.
Other recent agreements in Therapeutics and Pharmaceutical
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Edesa Biotech Enters Collaboration and License Agreement with Kyorin Pharmaceutical (November 9, 2026)
- Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026)
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- Celltrion Secures Exclusive Supply Agreement for Omlyclo and Aptozma with U.S. Healthcare Company to Expand Market Access. (October 26, 2026)
Related People
Agreement Insights
What this usually meansPfizer signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.